dual glp-1/gip receptor agonists and Triple Gut Peptide on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data | Current Obesity Reports Targeting GLP-1, GIP & GCG
Description
You can watch by clicking this link here this link here Want More Like This
Interestingly, the nausea they cause isnt necessary for weight loss, as these effects are managed by brain cells separate from those regulating feelings of fullness
If you can afford both, the literature does not show meaningful additive benefit at typical doses
doi:10.1111/dom.12165
